Shenzhen Cell Valley visited the Hong Kong Eastern District Hospital to discuss the clinical cooperation of cell therapy
Recently, the Shenzhen cell valley chairman and general manager professor history, chief scientist professor Wang Jianxun, chairman assistant Dr FuYuchen, marketing minister ms Sun Rui and subsidiary —— Hong Kong cell valley general manager Mr Zhou Zhaobin a line, visit Hong Kong's largest public hospital you MrsThat dozen hospital (Pamela Youde Nethersole Eastern Hospital, hereinafter referred to as Hong Kong east hospital) to visit. Dr. Su Jieying, director of Hong Kong Hospital Authority and Hong Kong Island East Hospital, warmly received him with the core team and arranged a discussion and exchange meeting. Dr. Chung, Chairman of the Greater China Cancer Foundation, gentlemen of Hong Kong and renowned philanthropist Dr. Chung also attended the meeting, and the two sides had an in-depth discussion on the promotion of the cell therapy clinical project.
Under the professional guidance of Dr. Chen Juan, clinical oncology consultant and Dr. Xu Zishan, the visiting team visited the key departments of Hong Kong Eastern Hospital, including clinical oncology and the Department of Hematology and Hematology. Through the field visits, the team had a comprehensive understanding of the overall hospital operation, hospital's professional facilities and medical service process. With 2,000 beds and more than 6,000 employees, the Eastern District Hospital provides public health services in the eastern part of Hong Kong Island. It is worth noting that the East side of Hong Kong Island is one of the most severely aging regions among the 18 districts in Hong Kong, with the population over 60 accounting for nearly 30% of the total population, significantly higher than the average level of 21% in Hong Kong, which makes the medical needs of the region particularly urgent.
At the symposium, Professor Shi Said that Shenzhen Cell Valley is actively promoting the internationalization strategic layout, and established the overseas wholly-owned subsidiary —— Hong Kong Cell Valley, which has always been committed to maintaining close communication and cooperation with the Hong Kong Medical Authority and major medical institutions. At present, Shenzhen Cell Valley has reached the intention of clinical application and scientific research cooperation with the main hospitals in the Hong Kong Island East Hospital, and is making every effort to promote the application of the entry and exit procedures of cell products, to facilitate the smooth progress of the cooperation projects between Shenzhen and Hong Kong.
Hong Kong hospital authority of Hong Kong island east hospital networking director Su Jieying doctor expounds the Hong Kong east hospital advantages in the field of clinical research and medical technology, and further points out that recently through many kiss in Shenzhen cell valley headquarters and cooperation of medical institutions of in-depth exchanges, in Shenzhen cell valley strong, east hospital and Shenzhen public 3 armour hospital established preliminary relations of cooperation between, jointly carried out a series of academic exchange activities. At the meeting, Chung Kim Chung, chairman of the Greater China Cancer Foundation, shared the achievements of the Foundation in cancer prevention and treatment, and said that the foundation fully supports the medical cooperation between Shenzhen and Hong Kong, and is committed to providing high-quality medical services and affordable cancer drugs and technologies for low-income cancer patients in Hong Kong.
At the end of the symposium, the participants had in-depth discussions on the details of future cooperation in the field of clinical treatment. All parties agreed that joint efforts could further promote the coordinated development of Shenzhen and Hong Kong in the medical field and bring more positive and significant health benefits to patients in both places.
Hong Kong hospital authority of Hong Kong island east hospital networking director Su Jieying doctor expounds the Hong Kong east hospital advantages in the field of clinical research and medical technology, and further points out that recently through many kiss in Shenzhen cell valley headquarters and cooperation of medical institutions of in-depth exchanges, in Shenzhen cell valley strong, east hospital and Shenzhen public 3 armour hospital established preliminary relations of cooperation between, jointly carried out a series of academic exchange activities. At the meeting, Chung Kim Chung, chairman of the Greater China Cancer Foundation, shared the achievements of the Foundation in cancer prevention and treatment, and said that the foundation fully supports the medical cooperation between Shenzhen and Hong Kong, and is committed to providing high-quality medical services and affordable cancer drugs and technologies for low-income cancer patients in Hong Kong.
At the end of the symposium, the participants had in-depth discussions on the details of future cooperation in the field of clinical treatment. All parties agreed that joint efforts could further promote the coordinated development of Shenzhen and Hong Kong in the medical field and bring more positive and significant health benefits to patients in both places.
